Evidence map›Paper›PMID 42182417›Full record

ArticlebioRxiv : the preprint server for biology2026

Chronic TGFβ1 Signaling Drives Aberrant Alveolar-Basaloid Metaplasia through a KRT17-Stratifin migratory complex.

Isha R Sahasrabudhe, Xinran Ma, Stefano A Iantorno, Tristan Tran, Sachin DSouza, Chaya Sussman, Dakota Jones, Mauer Biscotti, Ivy Cao, Jeremy Katzen and 4 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Isha R SahasrabudheDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY.
Xinran MaDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY.
Stefano A IantornoDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
Tristan TranDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY.
Sachin DSouzaDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY.
Chaya SussmanDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY.
Dakota JonesCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.
Mauer BiscottiPenn-CHOP Lung Biology Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Ivy CaoPenn-CHOP Lung Biology Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Jeremy KatzenPenn-CHOP Lung Biology Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Maria C BasilPenn-CHOP Lung Biology Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Jaime L HookDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY.
Konstantinos-Dionysios AlysandratosCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.
Jaymin J KathiriyaDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai (ISMMS), New York, NY.

Funding

Patient-specific iPSCs to model and treat the inception of pulmonary fibrosisP01HL170952 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Darrell N. Kotton · 2024 to 2026
$11.4M
Research Supplement for Alveolar Responses to Viral Lung InfectionR01HL164821 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Jaime Lynn Hook · 2022 to 2026
$2.6M
The Penn LungMAP 3 team: Defining chronic lung diseaseU01HL175409 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI EDWARD E MORRISEY · 2024 to 2026
$2.3M
Sources and Regulation of Epithelial Stem/Progenitor Cells in Alveolar RegenerationR00HL155785 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KATHIRIYA, JAYMIN J · 2023 to 2025
$747k
Utilizing induced pluripotent stem cells to study the role of alveolar type 2 cell dysfunction in pulmonary fibrosisK08HL163494 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Konstantinos Alysandratos · 2023 to 2026
$649k
Epigenetic signatures driving metaplastic repair mechanisms in human alveolar type II cellsF32HL175915 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Stefano Azelio Iantorno · 2024 to 2026
$265k
NHLBI NIH HHS F32 HL175915NHLBI NIH HHS K08 HL163494NHLBI NIH HHS P01 HL170952NHLBI NIH HHS R00 HL155785NHLBI NIH HHS R01 HL164821NHLBI NIH HHS U01 HL175409
6 · The paper itself

Abstract

Chronic fibrotic disorders like idiopathic pulmonary fibrosis (IPF) are characterized by aberrant alveolar regeneration and severely limited treatment options. Identification of the mechanisms driving aberrant epithelial repair can lead to new viable therapeutic targets. Using integrated single nucleus ATAC- and RNA-sequencing on human lungs and an in vitro model of dysplastic repair, we identify two distinct regenerative trajectories for alveolar type 2 (AT2) cells: a resolvable euplastic repair trajectory and a persistent, non-resolving dysplastic repair trajectory. The latter is governed by a spatially restricted ITGB6/TGFβ1/SMAD3 signaling axis in fibrotic regions of IPF lungs and in murine lungs characterized by chronic epithelial remodeling. Mechanistically, SMAD3 directly regulates dysplastic transitional cell (DTC) markers, including KRT17 and Stratifin. We show that TGFβ1 signaling promotes a physical interaction between KRT17 and Stratifin at the leading edge of migrating DTCs

Identifiers

PMID42182417
PMCPMC13192666

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.